51只个股今日获机构买入型评级，11股机构首次关注。 证券时报·数据宝统计显示，今日机构研报共发布53条买入型评级记录，共涉及51只个股。吉宏股份、 安井食品等关注度最高，均有2次机构买入型评级记录。 今日获机构买入型评级个股中，共有15条评级记录中对相关个股给出了未来目标价。以公布的预测目标 价与最新收盘价进行对比显示，共有10股上涨空间超20%，今世缘上涨空间最高，5月22日华创证券预 计公司目标价为75.00元，上涨空间达63.04%，上涨空间较高的个股还有合百集团、金帝股份等，上涨 空间分别为50.80%、39.76%。 从机构评级变动看，今日机构买入型评级记录中，有11条评级记录为机构首次关注，涉及博众精工、鼎 通科技等11只个股。 | | | （文章来源：证券时报网） 市场表现方面，机构买入型评级个股今日平均下跌1.19%，表现弱于沪指。股价上涨的有11只，涨幅居 前的有安井食品、东安动力、福耀玻璃等，今日涨幅分别为3.46%、3.29%、3.20%。跌幅较大的个股有 捷众科技、欧福蛋业、科锐国际等，跌幅分别为9.38%、5.84%、4.09%。 行业来看，电力设备行业最受青睐，富临精工、通达股份 ...

Group 1 - The core viewpoint of the articles indicates that the Chinese liquor industry, particularly the baijiu sector, is transitioning from a phase of high-speed growth to a more stable and quality-focused development phase, as evidenced by the revenue growth targets set by major companies like Moutai for 2025 [1][8][12] - Moutai has set a revenue growth KPI of 9% for 2025, which is a significant reduction compared to previous years' double-digit growth targets, reflecting the company's adaptation to current industry challenges [1][8] - Other leading baijiu companies have either not set specific growth targets for 2025 or have lowered their expectations, indicating a broader industry trend towards prioritizing stability over aggressive growth [2][10][11] Group 2 - In 2024, the overall performance of the baijiu industry is expected to slow down, with 22 listed baijiu companies projected to achieve a combined revenue of 446.22 billion yuan and a net profit of 167.82 billion yuan, both showing a marked decline in growth rates compared to previous years [2][3] - Major companies like Wuliangye, Luzhou Laojiao, and Yanghe have struggled to meet their revenue targets for 2024, with some reporting only single-digit growth despite having set higher expectations [3][4][7] - The industry is facing significant challenges, including high inventory levels, price conflicts between traditional channels and e-commerce, and changing consumer preferences, which are prompting companies to adopt more conservative growth strategies [12]

5月22日，A股市场整体下跌。 截至收盘，上证指数收报3380.19点，下跌0.22%；深证成指收报10219.62点，下跌0.72%；创业板指收报 2045.57点，下跌0.96%。两市合计成交11026.9亿元，较上一交易日减少707.55亿元。 1. 两市主力资金净流出超250亿元 今日沪深两市主力资金开盘净流出57.48亿元，尾盘净流出41.77亿元，全天净流出252.63亿元。 | | | 沪深两市最近五个交易日主力资金流向情况(亿元) | | | | --- | --- | --- | --- | --- | | 日期 | | 净流入金额 开盘净流入 | 尾盘净流入 | 超大单净买入 | | 2025-5-22 | -252. 63 | -57.48 | -41.77 | -104. 55 | | 2025-5-21 | -229.13 | -102. 74 | -15. 22 | -82.09 | | 2025-5-20 | -19.30 | -67.28 | 4. 68 | 46. 36 | | 2025-5-19 | -124.08 | -134.53 | -1. 67 | -37.99 | ...

Investment Rating - The report maintains a "Strong Buy" rating for the company with a target price of 75 CNY [1] Core Views - The company is actively pursuing growth strategies during a challenging industry phase, focusing on optimizing its organizational structure and enhancing execution efficiency [7] - The company has established itself as a leader in the 100-500 CNY price range within its home province, with ongoing opportunities for market expansion [7] - The company is making significant strides in its V series and expanding its presence in markets outside its home province, particularly in the Yangtze River Delta region [7] - The company has shown resilience in maintaining stable pricing and strong sales performance during the seasonal downturn, with a notable increase in banquet events during the May Day holiday [7] - The company is expected to achieve steady revenue growth, with projected total revenue of 11,546 million CNY in 2024, reflecting a year-on-year growth rate of 14.3% [3] Financial Summary - Total revenue projections for 2024A, 2025E, 2026E, and 2027E are 11,546 million CNY, 12,578 million CNY, 13,641 million CNY, and 14,695 million CNY respectively, with corresponding growth rates of 14.3%, 8.9%, 8.5%, and 7.7% [3] - The net profit attributable to shareholders is projected to be 3,412 million CNY in 2024A, with growth rates of 8.8%, 6.9%, 7.8%, and 7.8% for the following years [3] - Earnings per share (EPS) are forecasted to be 2.74 CNY for 2024A, increasing to 3.40 CNY by 2027E [3] - The company’s price-to-earnings (P/E) ratio is expected to decrease from 17 in 2024A to 14 in 2027E, indicating potential value for investors [3]

Core Viewpoint - The recent "ban on alcohol" has limited short-term impact on the liquor industry, but it may significantly influence the strategic layout of liquor companies and alter the industry landscape [1][2][3]. Summary by Sections Impact of the New Ban - The new ban is issued by the central government, marking a shift from previous local regulations, and it imposes stricter standards on alcohol consumption in government settings [1][2]. - The 2025 revised regulations explicitly prohibit all alcoholic beverages in work meals, affecting state-owned enterprises and financial institutions [2][3]. Market Reaction and Consumption Trends - The proportion of government consumption in liquor sales has decreased from 40% in 2011 to around 5% currently, suggesting that the direct revenue impact of the new ban will be minimal [2][5]. - The new regulations are linked to recent incidents involving officials and alcohol, which may lead to temporary market volatility but are not expected to fundamentally alter investment logic in the liquor sector [2][3]. Brand and Market Dynamics - The new ban is unlikely to replicate the severe market downturn seen after the 2012 "Eight Regulations," as high-end brands like Moutai remain essential in business settings [3][5]. - Moutai's sales from government channels are estimated to be around 2% of total sales, indicating limited exposure to the new regulations [5][6]. - The ban may disproportionately affect mid-tier brands that rely on government consumption for brand prestige, while high-end brands maintain their market position [5][6]. Long-term Industry Evolution - The series of alcohol bans over the years has gradually shifted the liquor industry from policy dependence to market-driven dynamics, leading to significant changes in industry structure [7][8]. - Current consumption scenarios show that family gatherings, social events, and business dinners are the top three contexts for liquor consumption, highlighting the need for brands to adapt to changing consumer preferences [8][11]. Future Outlook - The industry is expected to continue evolving, with companies like Moutai and Wuliangye exploring new consumption scenarios and lifestyle branding to maintain relevance [11][12]. - Investors are advised to monitor the sector for potential recovery signals, with expectations for a market turnaround possibly extending to late 2025 or 2026 [12].

Investment Rating - The report maintains a "Strong Buy" rating for the company with a target price of 75 yuan [1] Core Views - The company is actively pursuing growth strategies during a challenging industry phase, focusing on optimizing its organizational structure and enhancing execution efficiency [7] - The company has established itself as a leader in the 100-500 yuan price range within its home province, with ongoing efforts to expand market share and explore growth opportunities in both domestic and provincial markets [7] - The company is making significant strides in its V series and expanding its presence in provincial markets, particularly in the Yangtze River Delta region, which is expected to contribute to long-term growth [7] - The company has shown resilience in maintaining stable pricing and operational performance, with a notable increase in banquet events during the May Day holiday [7] - The report forecasts steady revenue growth, with total revenue projected to reach 11,546 million yuan in 2024, reflecting a year-on-year growth rate of 14.3% [3] Financial Summary - Total revenue projections for 2024A, 2025E, 2026E, and 2027E are 11,546 million yuan, 12,578 million yuan, 13,641 million yuan, and 14,695 million yuan respectively, with corresponding growth rates of 14.3%, 8.9%, 8.5%, and 7.7% [3] - The net profit attributable to the parent company is expected to be 3,412 million yuan in 2024A, increasing to 4,235 million yuan by 2027E, with growth rates of 8.8%, 6.9%, 7.8%, and 7.8% for the respective years [3] - Earnings per share (EPS) are projected to be 2.74 yuan in 2024A, rising to 3.40 yuan by 2027E [3] - The company’s price-to-earnings (P/E) ratio is forecasted to decrease from 17 in 2024A to 14 in 2027E, indicating potential value for investors [3]

Group 1: Macro Analysis - The report analyzes the risk of a sell-off in US Treasury bonds, indicating that the scale of US Treasury holdings and daily trading volume is significantly larger than that of any other country, suggesting that no single nation can manipulate the US Treasury market [2] - Historical data shows that reductions in overseas holdings have less impact on US Treasury trends compared to fundamental variables, but a coordinated sell-off by multiple countries in response to tariffs could significantly disrupt the US Treasury market and global financial markets [2] Group 2: Fixed Income - In April, the broad fiscal revenue showed a slight positive change with a year-on-year increase of 2.7%, while fiscal expenditure grew by 12.9% year-on-year, indicating an acceleration in spending [2] - Cumulatively, from January to April, broad fiscal revenue decreased by 1.3% year-on-year, while broad fiscal expenditure increased by 7.2% [2] Group 3: Food and Beverage Industry - Investment recommendations for the liquor sector emphasize strengthening core capabilities and highlight three main lines: leading brands with increasing market share, high-certainty regional brands, and resilient recovery stocks [3] - For consumer products, the report suggests focusing on opportunities in beer and beverages, with a particular emphasis on companies benefiting from policy changes or recovery improvements, as well as those with high growth potential [3] Group 4: Pharmaceutical Industry - The report discusses the collaboration between Sanofi and Pfizer regarding the PD-1/VEGF bispecific antibody SSGJ-707, which includes a non-refundable upfront payment of $1.25 billion and potential milestone payments up to $4.8 billion [6] - Sanofi retains rights for development and commercialization in mainland China, while Pfizer will have an option for commercialization in that region based on agreed financial terms [6]

Core Insights - The articles contain fragmented and unclear information, making it difficult to extract coherent insights regarding specific companies or industries. Group 1 - The data includes various numerical values and percentages, but lacks context or clear relevance to specific companies or industry trends [1][2][3] - There are references to potential financial metrics, but without clear definitions or explanations, the significance remains ambiguous [2][3] Group 2 - The documents appear to be corrupted or improperly formatted, leading to a lack of actionable insights or relevant information for investment analysis [1][2][3] - No specific companies or industries are mentioned in a clear manner, limiting the ability to derive meaningful conclusions [1][2][3]

证券代码：603369 证券简称：今世缘 公告编号：2025-020 江苏今世缘酒业股份有限公司 2024年年度股东大会决议公告 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 5 月 21 日 (二)股东大会召开的地点：江苏省淮安市涟水县高沟镇今世缘大道 1 号江苏今世 缘酒业股份有限公司一楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 25 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 737,661,461 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股份总 | | | 数的比例（%） | 59.1644 | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 公司本次股东大会采用现场投票和网络投票相结合的表决方式，表决方式符合 《公司法》及公司《章程》的规定；会议由 ...

!"#$%&"'()*+, . / 0123456789:;< =>=? @ @ A 7B#CD !"#$% www.dentons.cn !"#$%&'() 18 *+,-. A / 7-11 012100362 18 Jihui Road, 7-11/F of Building A, Lianchuang Mansion, Gulou District,Nanjing,China,210036 Tel: +86-25-8375 5101 Fax: +86-25-8375 5005 北京大成(南京)律师事务所 关于江苏今世缘酒业股份有限公司 2024 年年度股东大会的法律意见书 致:江苏今世缘酒业股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民 共和国公司法》（以下简称"《公司法》"）和中国证券监督管理委员会《上市 公司股东会规则》（以下简称"《股东会规则》"）等法律、法规和其他有关规 范性文件的要求,北京大成(南京)律师事务所(以下简称"本所")接受江苏 今世缘酒业股份有限公司（以下简称"公司"）的委托，指派律师参加公司 2024 年年度股东大会（以下简称"本次股东大会"） ...